Accueil>>Signaling Pathways>> TGF-β / Smad Signaling>>Luspatercept

Luspatercept (Synonyms: ACE-536; luspatercept-aamt)

Catalog No.GC69412

Luspatercept (ACE-536) est une protéine de fusion recombinante modifiée qui se lie aux ligands de la super-famille du facteur de croissance transformant β. Luspatercept augmente le nombre de globules rouges et favorise la maturation des précurseurs des globules rouges. Luspatercept se lie à GDF11, inhibe la voie de signalisation Smad2/3 et peut être utilisé dans la recherche sur l'anémie.

Products are for research use only. Not for human use. We do not sell to patients.

Luspatercept Chemical Structure

Cas No.: 1373715-00-4

Taille Prix Stock Qté
1mg
405,00 $US
En stock
5mg
1 053,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Avis

Review for Luspatercept

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Luspatercept

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.